Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 30 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

17%

5 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed trials have results

Key Signals

14 recruiting1 with results

Enrollment Performance

Analytics

N/A

9(42.9%)

Phase 2

6(28.6%)

Phase 4

3(14.3%)

Phase 3

2(9.5%)

Phase 1

1(4.8%)

21Total

N/A(9)

Phase 2(6)

Phase 4(3)

Phase 3(2)

+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (30)

Showing 20 of 30 trials

NCT07548281Not ApplicableNot Yet Recruiting

Intravascular Ultrasound- and Angiography-Derived Fractional Flow Reserve-Guided Drug-Coated Balloon for Large Coronary Artery De Novo Lesions

Role: collaborator

NCT07518810Phase 2Not Yet Recruiting

Efficacy and Safety of Butylphthalide in the Treatment of Multiple System Atrophy

Role: collaborator

NCT07507825Phase 2Not Yet Recruiting

Exploratory Study of Venetoclax, Homoharringtonine, Azacitidine Plus G-CSF for Newly Diagnosed AML (VHAG)

Role: collaborator

NCT07480785Not ApplicableRecruiting

TEAS Combined With Triple Antiemetic Drugs to Prevent PONV in High-Risk Patients

Role: collaborator

NCT07451158Not ApplicableActive Not Recruiting

Multicenter, Double-blind, and Randomized Controlled Trial of Ultra-Distal TENS Device for Migraine Treatment

Role: collaborator

NCT07385131Recruiting

Prophylactic Dexamethasone Before Infliximab in Moderate-to-Severe IBD

Role: collaborator

NCT06596005Phase 2Completed

Efficacy and Safety of TJ0113 Capsule in Patients With Parkinson's Disease

Role: collaborator

NCT07344545Completed

Mining the Gut Microbiota of Adults for Health-relevant Microbial Signatures.

Role: collaborator

NCT05722405Phase 4Recruiting

Ixazomib Plus Low-dose Lenalidomide Versus Ixazomib Alone for Maintenance Treatment of High Risk Multiple Myeloma

Role: collaborator

NCT07266168Not ApplicableNot Yet Recruiting

Efficacy and Safety of Ivarmacitinib in the Treatment of Patients With Polymyalgia Rheumatica

Role: collaborator

NCT06520163Phase 3Recruiting

Comparison Study of EAP and Disease-Specific Chemotherapy Regimens in Hematopoietic Stem Cell Mobilization for Lymphoma

Role: collaborator

NCT03957707Not ApplicableActive Not Recruiting

Sterotactic Operation Integrating With Thrombolysis in Basal Ganglion Hemorrhage Evacuation

Role: collaborator

NCT07203248Not Yet Recruiting

Chinese Real-world Study of Treatment of Vestibular Migraine

Role: collaborator

NCT07169903Phase 3Not Yet Recruiting

Segmentectomy vs Lobectomy for 2 - 3cm IASLC Grade 1-2 Lung Adenocarcinoma: A Multi-center RCT

Role: collaborator

NCT07078500Phase 2Recruiting

Orelabrutinib Combined With Pola-R-CHP Regimen for the Treatment of Untreated Non-GCB Diffuse Large B-Cell Lymphoma

Role: collaborator

NCT07114107Not ApplicableNot Yet Recruiting

Vibroacoustic Therapy With Oscillating Positive Expiratory Pressure in the Treatment of Nasal Congestion

Role: collaborator

NCT04961515Phase 2Recruiting

Orelabrutinib, Sintilimab and Temozolomide in Relapsed or Refractory Central Nervous System Lymphoma

Role: collaborator

NCT06968962Not ApplicableRecruiting

Comparison of Sequential to Initial Combination Therapy in PAH

Role: collaborator

NCT04939922Recruiting

China Headache and Vertigo Registry Study

Role: collaborator

NCT05439135Not ApplicableRecruiting

Washed Microbiota Transplantation for Malnutrition After Nonphysiological Reconstruction of the Upper Gastrointestinal Tract

Role: collaborator